IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $122,000 | +154.2% | 2,769 | +238.5% | 0.01% | +600.0% |
Q2 2020 | $48,000 | -86.2% | 818 | -89.6% | 0.00% | -87.5% |
Q1 2018 | $348,000 | -12.3% | 7,901 | 0.0% | 0.01% | -11.1% |
Q4 2017 | $397,000 | -1.0% | 7,901 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $401,000 | +51.9% | 7,901 | +52.4% | 0.01% | +50.0% |
Q2 2017 | $264,000 | +26.9% | 5,184 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $208,000 | -59.7% | 5,184 | -51.9% | 0.01% | -58.3% |
Q4 2016 | $516,000 | – | 10,787 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |